Sofinnova Investments, Inc. Compugen LTD Transaction History

Sofinnova Investments, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$12.07 - $17.95 $1.77 Million - $2.63 Million	-146,592 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$14.16 - $19.45 $608,950 - $836,447	43,005 Added 41.52%	146,592 $2.38 Million
Q2 2020 Aug 13, 2020	SELL	$6.97 - $17.12 $1.37 Million - $3.36 Million	-196,413 Reduced 65.47%	103,587 $1.56 Million
Q1 2020 May 13, 2020	BUY	$5.79 - $11.83 $1.74 Million - $3.55 Million	300,000 New	300,000 $2.18 Million

13.3M

191K

135K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $142M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.